- Home
- GIGM vs JAGX Comparison
GIGM vs JAGX Comparison
Compare GIGM & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- JAGX
- Stock Information
- Founded
- GIGM 1998
- JAGX 2013
- Country
- GIGM Taiwan
- JAGX United States
- Employees
- GIGM N/A
- JAGX N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- GIGM Technology
- JAGX Health Care
- Exchange
- GIGM Nasdaq
- JAGX Nasdaq
- Market Cap
- GIGM N/A
- JAGX 3.1M
- IPO Year
- GIGM 2000
- JAGX N/A
- Fundamental
- Price
- GIGM $1.68
- JAGX $4.67
- Analyst Decision
- GIGM
- JAGX
- Analyst Count
- GIGM 0
- JAGX 0
- Target Price
- GIGM N/A
- JAGX N/A
- AVG Volume (30 Days)
- GIGM 18.2K
- JAGX 39.3K
- Earning Date
- GIGM 03-28-2025
- JAGX 03-31-2025
- Dividend Yield
- GIGM N/A
- JAGX N/A
- EPS Growth
- GIGM N/A
- JAGX N/A
- EPS
- GIGM N/A
- JAGX N/A
- Revenue
- GIGM $2,969,000.00
- JAGX $11,689,000.00
- Revenue This Year
- GIGM N/A
- JAGX $18.18
- Revenue Next Year
- GIGM N/A
- JAGX $40.06
- P/E Ratio
- GIGM N/A
- JAGX N/A
- Revenue Growth
- GIGM N/A
- JAGX 19.75
- 52 Week Low
- GIGM $1.26
- JAGX $4.40
- 52 Week High
- GIGM $1.80
- JAGX $540.00
- Technical
- Relative Strength Index (RSI)
- GIGM 59.18
- JAGX 20.41
- Support Level
- GIGM $1.48
- JAGX $4.41
- Resistance Level
- GIGM $1.78
- JAGX $4.97
- Average True Range (ATR)
- GIGM 0.05
- JAGX 0.88
- MACD
- GIGM 0.00
- JAGX 0.09
- Stochastic Oscillator
- GIGM 45.45
- JAGX 3.35
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.